첫 페이지 News 본문

On January 18th, the US stock market of cancer company Aravive plummeted by over 57% to $0.046. Previously, the company announced that it would voluntarily delist from the Nasdaq Global Select Market and revoke the registration of its common stock.
您需要登录后才可以回帖 登录 | Sign Up

本版积分规则

楚一帆 注册会员
  • Follow

    0

  • Following

    0

  • Articles

    38